Skip to main content

Table 1 Randomized trials comparing dalteparin or enoxaparin in THR patients

From: Meta regression analysis to indirectly compare dalteparin to enoxaparin for the prevention of venous thromboembolic events following total hip replacement

Study

Sample Size (n)

Study Drug vs. Control

Results (n)

Major Bleeds (n)

HIT (n)

Deaths (n)

Dechavanne,1989 [17]

D1 = 42

D2 = 41

H = 41

D - 2500 IU SC 2 h pre-op, then q 12 h post-op × 10-13 days

DVT (all)

D1 - 2

D2 - 3

H - 4

 

D1 - 0

D2 - 0

H - 0

 
  

D - 2500 IU SC 2 h pre-op, then q 12 h post-op × 48 h, then 5000 IU q AM × 10-13 days

DVT (proximal)

D1 - 1

D2 - 1

H - 3

   
  

H - 5000 IU SC 2 h pre-op, then bid × 2 days post-op, then H dosage was adjusted according to aPTT × 10-13 days

    

Tørholm, 1991 [16]

D = 60

P = 60

D - 2500 IU SC 2 h pre-op and 12 h post-op, then 5000 IU qAM × 6 days

DVT

D - 9

P - 19

  

D - 1

P - 0

  

P - 2 h pre-op and 12 h post-op, then qAM × 6 days

PE

D - 0

P - 1

   

Dahl, 1997 [19]

D = 134

P = 131

D - 5000 IU SC evening before op and qPM × 7 days, then 5000 IU SC qPM × 28 days (±2 days)

DVT within first 7 days

D - 4

P - 3

 

D - 0

P - 0

D - 0

P - 0

  

P - 5000 IU SC evening before op and qPM × 7 days, then placebo × 28 days (±2 days)

DVT within 35 days

D - 22

P - 23

   
   

PE within 35 days

D - 0

P - 1

   

Lassen, 1998 [20]

D = 140

P = 141

D - 5000 IU SC qd, starting 12 h pre-op and × 7 days post-op; then 5000 IU qd × 28 days

DVT (all)

D - 5

P - 12

D - 0

P - 1

D - 0

P - 1

 
  

P - 5000 IU SC qd, starting 12 h pre-op and × 7 days post-op; then placebo × 28 days

DVT (proximal)

D - 1

P - 5

   
   

PE

D - 0

P - 0

   

Hull, 2000a [21]

D1 = 504

D2 = 494

W = 500

D1 (pre-op) - 2500 IU SC within 2 h before surgery, then 2500 IUSC 4 or more h after surgery, then 5000 IU SC qAM × 6 days (±2)

DVT (all)

D1 - 36

D2 - 44

W - 81

First 8 days

D1 - 44

D2 - 32

W - 22

D1 - 6

D2 - 4

W - 10

D1 - 2

D2 - 0

W - 2

  

D2 (post-op) - Placebo within 2 h before surgery, then 2500 IU SC 4 h or more after surgery, then 5000 IU SC qAM × 6 days (±2)

DVT (proximal)

D1 - 3

D2 - 3

W - 11

   
  

W - 10 mg PO evening after surgery (5 mg if ≥ 70 years old), then qd dosing by nomogram × 6 days (±2)

PE

D1 - 0

D2 - 0

W - 0

   

Hull, 2000b [22]

D1 = 199

D2 = 190

W = 180

D (pre-op) - 2500 IU SC within 2 h before surgery, then 2500 IU SC 4 or more h after surgery, then 5000 IU qAM in-hospital, then 5000 IU qd up to 35 days (±2)

DVT (all) out of hospital within first 35 days

D1 - 8

D2 - 6

P - 14

Major bleeds out of hospital within first 35 days

D1 - 0

D2 - 0

P - 0

D1 - 0

D2 - 0

P - 0

D1 - 0

D2 - 0

P - 1

  

D (post-op) - 2500 IU SC 4 or more h after surgery, then 5000 IU qAM in-hospital; then 5000 IU qd up to 35 days (±2)

DVT (proximal) out of hospital within first 35 days

D1 - 2

D2 - 1

P - 7

   
  

W - 10 mg PO evening after surgery (5 mg if ≥ 70 years old or < 57 kg), then qd dosing by nomogram in-hospital, then placebo up to 35 days (±2)

PE out of hospital within first 35 days

D1 - 0

D2 - 0

P - 0

   

Turpie, 1986 [23]

E = 50

P = 50

E - 30 mg SC bid, started 12-24 h post-op, then qd × 14 days or until discharge

DVT (all)

E - 6

P - 21

E - 1

P - 2

 

E - 0

P - 1

  

P - 30 mg placebo SC bid started 12-24 h post-op, then × 14 days or until discharge

DVT (proximal)

E - 2

P - 10

   
   

PE

E - 0

P - 0

   

Planes, 1988 [24]

E = 124

H = 113

E - 40 mg SC starting 12 h (the day before surgery) pre-op, then qd × 14 days or until discharge

DVT (all)

E - 15

H - 27

E - 2

H - 0

 

E - 0

H - 0

  

H - 5000 IU SC starting 2 h (on the day of surgery) pre-op, then tid × 14 days or until discharge

DVT (proximal)

E - 9

H - 20

   
   

PE

E - 2

H - 3

   

Levine, 1991 [25]

E = 333

H = 332

E - 30 mg SC bid, starting 12-24 h post-op, then bid × 14 days or until discharge

DVT (all)

E - 57

H - 63

E - 11

H - 19

E - 0

H - 2

E - 0

H - 0

  

H - 7500 IU SC bid, starting 12-24 h post-op, then bid × 14 days or until discharge

DVT (proximal)

E - 16

H - 18

   
   

PE

E - 0

H - 1

   

Colwell, 1994 [26]

E1 = 195

E2 = 205

H = 210

E1 - 30 mg SC q 12 h × 7 days E2 - 40 mg SC qdx 7 days H - 5000 IU SC q 8 h × 7 days

DVT (all)

E1 - 9

E2 - 30

H - 24

E1 - 8

E2 - 3

H - 13

E1 - 7

E2 - 3

H - 5

E1 - 1

E2 - 0

H - 2

   

DVT (proximal)

E1 - 4

E2 - 8

H - 10

   
   

PE

E - 0

H - 3

   

Avikainen, 1995 [27]

E = 83

H = 84

E - 40 mg SC qd, starting 12 h pre-op, then qd × 10 days

DVT (all/proximal)

E - 1

H - 4

E - 7

H - 7

  
  

H - 5000 IU SC bid, starting 2 h pre-op and 12 h post-op, then bid × 10 days

PE

E - 0

H - 1

   

Bergqvist,1996 [28]

E = 131

P = 131

E - 40 mg SC qd starting 12 h pre-opx 7-11 days then 40 mg SC qd post-op × 21 days

DVT (all)

E - 21

P - 45

 

E - 1

P - 0

E - 0

P - 0

  

E P - 40 mg SC qd starting 12 h pre-op × 7-11 days then placebo qd post-op up to 21 days

DVT (proximal)

E - 8

P - 28

   
   

PE

E - 0

P - 2

   

Planes, 1996 [29]

E = 90

P = 89

E - 40 mg SC qd × 21 days P - qd × 21 days

DVT (all)

E - 6

P - 17

E - 0

P - 0

E - 0

P - 0

E - 0

P - 0

   

DVT (proximal)

E - 5

P - 7

   
   

PE

E - 0

P - 0

   

Rader, 1998 [30]

E = 70

H = 56

E - 5000 IU SC PM pre-op and AM and PM op day, then post-op enoxaprin 40 mg SC qd × 13-21 days

DVT (all)

E - 2

H - 1

E - 0

H - 0

  
  

H - 5000 IU SC PM pre-op and AM and PM op day, then 5000 IU SC tid × 3 days, then 7500 IU tid on 4th day post-op × 13-21 days

PE E - 0 H - 0

   

Comp, 2001 [31]

E = 224

P = 211

E - 30 mg SC bid, starting 12-24 h post-op and continuing 7-10 days; then enoxaparin 40 mg SC qd × 18-21 days

DVT (all)

E - 18

P - 49

E - 0

P - 0

E - 3

P - 2

 
  

P - enoxaparin 30 mg SC bid, starting 12-24 h post-op and continuing 7-10 days; then placebo qd × 18-21 days

DVT (proximal)

E - 6

P - 27

   
   

PE

E - 0

P - 1

   

Senaran, 2006 [32]

E = 50

H = 50

E - 40 mg SC qd, starting 12 h pre-op × 7-10 days until discharge

DVT during hospitalization (first 7-10 days)

E - 0

H - 2

E - 2

H - 0

E - 0

H - 0

E - 0

H - 0

  

H - 5000 IU SC, starting q 8 h pre-op, then continued to 15,000 IU qd in 3 equal doses q 8 h × 7-10 days until discharge

DVT within 45 days after discharge

E - 2

H - 0

   
  

* 45 day post discharge follow up

PE

E - 0

H - 0

   

Fuji, 2008 [33]

E1 = 104

E2 = 105

E3 = 107

P = 105

E1 - 20 mg SC qd, started 24-26 h post-op, then qd × 14 days

DVT (all)

E1 - 21

E2 - 18

E3 - 27

P - 36

E1 - 1

E2 - 3

E3 - 2

P - 0

  
  

E2 - 20 mg SC bid, started 24-26 h post-op then qd × 14 days

    
  

E3 - 40 mg SC qd, started 24-26 h post-op, then qd × 14 days

DVT (proximal)

E1 - 3

E2 - 3

E3 - 6

P - 9

   
  

P - qd × 14 days

    
  

*Follow-up at 90 days after surgery

PE

E1 - 0

E2 - 0

E3 - 0

P - 0

   
  1. Abbreviations: D = dalteparin, E = enoxaparin, P = placebo, H = unfractionated heparin, SC = subcutaneously, W = warfarin, IV = intravenously, THR = total hip replacement, HIT = heparin induced thrombocytopenia, VTE = Venous thromboembolism, S = symptomatic, DVT = deep vein thrombosis, PE = pulmonary embolism